Search Results - Mathieu Blery
- Showing 1 - 4 results of 4
-
1
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells by Loredana Ruggeri, Elena Urbani, Pascale André, Antonella Mancusi, Antonella Tosti, Fabiana Topini, Mathieu Bléry, Lucia Animobono, François Romagné, Nicolai Wagtmann, Andrea Velardi
Published in Haematologica (2016-05-01)Get full text
Article -
2
Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment by Tristan Courau, Julie Bonnereau, Justine Chicoteau, Hugo Bottois, Romain Remark, Laura Assante Miranda, Antoine Toubert, Mathieu Blery, Thomas Aparicio, Matthieu Allez, Lionel Le Bourhis
Published in Journal for ImmunoTherapy of Cancer (2019-03-01)Get full text
Article -
3
High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors by Antoine Marçais, Marie Marotel, Sophie Degouve, Alice Koenig, Sébastien Fauteux-Daniel, Annabelle Drouillard, Heinrich Schlums, Sébastien Viel, Laurie Besson, Omran Allatif, Mathieu Bléry, Eric Vivier, Yenan Bryceson, Olivier Thaunat, Thierry Walzer
Published in eLife (2017-09-01)Get full text
Article -
4
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control [version 2; peer review: 2 approved] by Mathieu Bléry, Manel Mrabet-Kraiem, Ariane Morel, Florence Lhospice, Delphine Bregeon, Cécile Bonnafous, Laurent Gauthier, Benjamin Rossi, Romain Remark, Stéphanie Cornen, Nadia Anceriz, Nicolas Viaud, Sylvia Trichard, Sabrina Carpentier, Alix Joulin-Giet, Gwendoline Grondin, Veronika Liptakova, Younghoon Kim, Laurent Daniel, Aurélie Haffner, Nicolas Macagno, Laurent Pouyet, Ivan Perrot, Carine Paturel, Yannis Morel, Alexander Steinle, François Romagné, Emilie Narni-Mancinelli, Eric Vivier
Published in Open Research Europe (2021-10-01)Get full text
Article